Key facts
- It has raised $2.9M; the latest was Seed Round ($2.8M) in Feb 2025.
- Notable investors include Right Side Capital Management, Service Provider Capital, Forum Ventures, Distributed Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Origin Therapy
- ·The full record, as it builds
Funding rounds
No funding rounds for Origin Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Origin Therapy
Provider of pediatric speech therapy services intended to support children with speech and language disorders. The company delivers in-home and teletherapy sessions, tracks progress, and creates personalized care plans, enabling children to develop communication skills, improve language abilities, and build confidence in expressing themselves.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 5
- Website
- origintherapy.com/
- Ownership
- Privately Held (backing)
Origin Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Origin Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Origin Therapy in its N-PORT filings yet. We sweep new filings monthly.